ガンマコロナウイルスの新型ナノ粒子ワクチンの開発と保護効果

Ting Xiong1,2, Yanfen Lyu1,2,3,4,5, Hongmei Li2

  • 1College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.

Vaccines
|August 28, 2025
PubMed
まとめ

新しいナノ粒子ワクチンは,感染性支気管炎ウイルス (IBV) GI-19 系統から鶏を効果的に保護しました. nAP205- S1ワクチンは優れた免疫反応と100%の保護を誘発し,家禽の健康に希望を示しました.

関連する概念動画

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144